{"id":"NCT00928434","sponsor":"Ferring Pharmaceuticals","briefTitle":"A Study of Degarelix in Patients With Prostate Cancer","officialTitle":"A Randomized, Controlled, Open-Label Study Investigating the Safety and Efficacy of Degarelix Given Intermittently vs Continuous Androgen Deprivation Therapy With Lupron or Degarelix in Patients With Prostate Cancer With Prior Treatment Failure After Localized Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-05","primaryCompletion":"2012-08","completion":"2012-08","firstPosted":"2009-06-26","resultsPosted":"2016-12-13","lastUpdate":"2016-12-13"},"enrollment":409,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Degarelix","otherNames":[]},{"type":"DRUG","name":"Degarelix","otherNames":[]},{"type":"DRUG","name":"Leuprolide","otherNames":[]}],"arms":[{"label":"DI (Degarelix Intermittent)","type":"EXPERIMENTAL"},{"label":"DC (Degarelix Continuous)","type":"EXPERIMENTAL"},{"label":"LC (Leuprolide Continuous)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to see if giving Degarelix every month for 7 months then stop treatment for 7 months (intermittent therapy) would show a reduction of negative effects of androgen deprivation therapy by increasing the quality of life while keeping prostate specific antigen (PSA) levels suppressed.","primaryOutcome":{"measure":"Percentage of Patients With Serum PSA Levels â‰¤4.0 ng/mL","timeFrame":"At 14 month","effectByArm":[{"arm":"DI (Degarelix Intermittent)","deltaMin":100,"sd":null},{"arm":"Total Continuous","deltaMin":98.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":12},"locations":{"siteCount":59,"countries":["United States"]},"refs":{"pmids":["34350976"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":175},"commonTop":["Hot flush","Injection site pain","Fatigue","Injection site erythema","Arthralgia"]}}